There is some exciting news dealing with the fight against mesothelioma. Scientists are using smart computers to figure out better ways to treat patients. This study is a first step towards making treatments that fit each person better. Mesothelioma is a tricky cancer, and finding the right treatments can be[…]
Novel Treatments & Drugs
Using Mesothelin Nanoprobes to Understand Certain Types of Mesothelioma
Mesothelioma is a tough cancer to have that is hard to diagnose and understand. Scientists are looking at a protein called mesothelin that could possibly help. This protein might be a clue to the cancer, but we need an easier way to find out more about it. In the new[…]
Fungus-Derived Compounds are Showing Promise Against Mesothelioma
Researchers in Japan have identified new chemical compounds derived from a fungus that showed the ability to kill mesothelioma cells in laboratory testing. The findings, published this month in the Journal of Antibiotics, are early-stage but add to a growing body of research exploring natural sources for new mesothelioma treatments.[…]
Artificial Intelligence Could Help Treat Mesothelioma
Diagnosing lung diseases can be hard because they have many causes and symptoms. Artificial intelligence (AI) may enable faster and more accurate diagnosis. AI could also play a significant role in improving outcomes for mesothelioma patients and other lung diseases. One common lung problem is pleural effusion. This can make[…]
Immunotherapy to Treat Pleural Effusion
Malignant pleural effusion is a serious condition where cancer cells spread to the lining of the lungs. This leads to fluid buildup in the chest cavity. This fluid accumulation can make breathing difficult and is often a sign of advanced lung cancer. Pleural effusion is a common symptom of malignant[…]
Tretinoin, a Derivative of Vitamin A, Could Improve the Anti-Cancer Effects of Chemotherapy on Mesothelioma
Tretinoin, a derivative of vitamin A, is showing potential to enhance the effects of chemotherapy. Combining tretinoin with chemotherapy improved survival rates in mesothelioma in mice. Mesothelioma is a rare type of cancer that is hard to diagnose and treat. It develops from the thin layer of tissue that covers[…]
Limited Surgery to Limit Symptoms of Pleural Mesothelioma
A new clinical trial at the University of Chicago is testing whether a smaller, symptom-focused surgery can help pleural mesothelioma patients maintain quality of life when tumor removal is not possible. This study looks at surgery differently compared to other trials. Rather than focusing first on complete tumor removal, it[…]
Radiomics to Determine Mesothelioma
Malignant mesothelioma is a challenging cancer to treat. New therapies like T cell receptor fusion constructs (TRuCs) show promise. Determining which patients will benefit from these treatments is important. Radiomics, a field that extracts data from medical images, offers a potential solution. Radiomics may predict treatment responses based on imaging[…]
PITAC to Treat Mesothelioma
A Stanford team performed a specialized procedure for pleural mesothelioma for the very first time in North America. It is known as pressurized intrathoracic aerosol chemotherapy (PITAC), and it delivers chemotherapy directly to the chest as a pressurized mist. One doctor knows it as “spray paint chemo.” PITAC is minimally[…]
Pleurectomy/Decortication Surgery Has Low Mortality When Patients are Carefully Selected
A new study out of the Icahn School of Medicine at Mount Sinai and the Mount Sinai Tisch Cancer Center finds lung-sparing pleurectomy/decortication (P/D) surgery has a very low rate of early mortality. These findings are in direct contrast to those from the MARS2 trial, which reported P/D surgery carried[…]
Skip to content